-
Adefovir serum levels do not differ between responders and nonresponders.
International audience -
SKI-1/S1P inhibition: a promising surrogate to statins to block hepatitis C v...
International audience -
Influenza pathogenesis: lessons learned from animal studies with H5N1, H1N1 S...
International audience -
Intranasal administration of alpha interferon reduces seasonal influenza A vi...
Financial support was provided by the German Ministry of Education and Research (FluResearchNet program to G.K., O.H., and P.S.), the Canadian Institutes of Health Research... -
Novel HCV replication mouse model using human hepatocellular carcinoma xenogr...
In the absence of an immunocompetent mouse model for HCV replication, we developed a convenient xenograft mouse model that produces infectious viral particles. For... -
Emerging viruses: risk of pandemic.
International audience -
Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of ...
International audience -
Pharmacological exposure to ribavirin: a key player in the complex network of...
International audience -
Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI2013...
International audience -
Biological Activities of Purified Marennine, the Blue Pigment Responsible for...
International audience -
Synthesis of C3-arylated-3-deazauridine derivatives with potent anti-HSV-1 ac...
International audience -
Treatment of recurrent HCV infection following liver transplantation: results...
International audience -
The treatment response of chronically hepatitis C virus-infected patients dep...
International audience -
Factors that predict response of patients with hepatitis C virus infection to...
International audience -
Sustained virological response after 14-day treatment with danoprevir and 48-...
International audience -
Fibrosis progression under maintenance interferon in hepatitis C is better de...
International audience -
Boceprevir for untreated chronic HCV genotype 1 infection.
International audience -
Effectiveness of chronic hepatitis C treatment in drug users in routine clini...
International audience -
Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in...
International audience -
Semen clusterin is a novel DC-SIGN ligand.
International audience
